Pathos AI
CHICAGO, Illinois, United States · Artificial Intelligence, Biotechnology, Health Care
Pathos is an AI-enabled biotechnology company focused on re-engineering drug development, leveraging the power of technology to bring precision medicine to patients through partnerships with pharmaceutical companies. Pathos has raised over $100 million to accelerate the development of precision medicines and to expand its platform, combining computational approaches across multimodal real-world da
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- CHICAGO, Illinois, United States
- Employees
- 98
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- pathos.com
- Company page
Recent activity at Pathos AI
- : Pathos AI, Inc. has closed $237 million in Series E financing, led by Bristol Myers Squibb, to scale their AI-driven drug development platform and advance their oncology pipeline.
- : Pathos AI and AstraZeneca Enter Co-Exclusive Licensing Agreement for AZD4241 in ER+ Breast Cancer Research.
- : Pathos AI
Employee benefit plans
Pathos AI files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Pathos AI: questions and answers
What does Pathos AI do?
Pathos is an AI-enabled biotechnology company focused on re-engineering drug development, leveraging the power of technology to bring precision medicine to patients through partnerships with pharmaceutical companies. Pathos has raised over $100 million to accelerate the development of precision medicines and to expand its platform, combining computational approaches across multimodal real-world da
Where is Pathos AI headquartered?
Pathos AI is headquartered in CHICAGO, Illinois, United States.
How many employees does Pathos AI have?
Pathos AI has about 98 employees.
What is the latest news on Pathos AI?
On Oct 23, 2026, Pathos AI, Inc. has closed $237 million in Series E financing, led by Bristol Myers Squibb, to scale their AI-driven drug development platform and advance their oncology pipeline.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy